Vivian Doan v. Asbestos Corporation, Ltd., Gaf Corporation

983 F.2d 1066, 1992 U.S. App. LEXIS 36968, 1992 WL 379436
CourtCourt of Appeals for the Sixth Circuit
DecidedDecember 15, 1992
Docket91-4019
StatusUnpublished
Cited by1 cases

This text of 983 F.2d 1066 (Vivian Doan v. Asbestos Corporation, Ltd., Gaf Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vivian Doan v. Asbestos Corporation, Ltd., Gaf Corporation, 983 F.2d 1066, 1992 U.S. App. LEXIS 36968, 1992 WL 379436 (6th Cir. 1992).

Opinion

983 F.2d 1066

NOTICE: Sixth Circuit Rule 24(c) states that citation of unpublished dispositions is disfavored except for establishing res judicata, estoppel, or the law of the case and requires service of copies of cited unpublished dispositions of the Sixth Circuit.
Vivian DOAN, Plaintiff-Appellee,
v.
ASBESTOS CORPORATION, LTD., Defendant-Appellant,
GAF Corporation, Defendant.

No. 91-4019.

United States Court of Appeals, Sixth Circuit.

Dec. 15, 1992.

Before RYAN and SUHRHEINRICH, Circuit Judges, and HIGGINBOTHAM, Senior Circuit Judge.*

RYAN, Circuit Judge.

Defendant Asbestos Corporation, Ltd. (ACL) seeks review of a judgment rendered after a bench trial in favor of plaintiff Vivian Doan in this asbestos products liability suit. Two issues are presented on appeal: first, whether the district court's findings on product identification, medical causation, and damages were clearly erroneous; and second, whether the district court's awards for damages and loss of consortium were excessive. Finding no error in the district court's rulings, we shall affirm.

I.

Plaintiff Vivian Doan, individually and as executrix of the estate of her husband, Fred Doan, filed a diversity-based products liability claim in the Southern District of Ohio against a number of asbestos suppliers. She based her claims on theories of strict liability and wrongful death for injuries her husband suffered, ultimately causing his death, as a result of his exposure to asbestos during his thirty-seven years of employment with Philip Carey/Celotex Corporation (Celotex). She also filed a loss of consortium claim. By the time the case proceeded to a bench trial, ACL was the only remaining defendant. All other defendants had either settled or had declared bankruptcy.

A. Work History

At trial, the following evidence was adduced mainly through the deposition testimony of Doan taken prior to his death and the deposition and trial testimony of other Celotex employees. Doan worked for Celotex's Lockland facility in Lockland, Ohio for thirty-seven years. Because Celotex produced asbestos products, asbestos fiber was used and processed in the plant during those thirty-seven years.

From 1946 to 1960, Doan worked in Celotex's rockwool department where he put rockwool in burlap bags that once contained asbestos. The bags came from two buildings at the Lockland facility where ACL asbestos fibers were used. The bags were not cleaned before Doan and his co-workers used them for bagging the rockwool, so the bagging created asbestos dust, which the workers inhaled. Once a week, Doan unloaded burlap bags, which were full of asbestos, from boxcars in Celotex building # 44. Occasionally, Doan also retrieved empty burlap bags from building # 44 for use in the rockwool department. Both activities created asbestos dust.

From 1960 to 1967, Doan worked in Celotex's Carey Temp Department where the company manufactured pipe covering and insulation. For two years, Doan's duties included sawing pipe insulation. According to a co-worker's testimony, because the insulation contained asbestos, the sawing created asbestos dust that became so heavy the sawers were required to go to a window for fresh air every twenty minutes.

From 1967 to 1983, Doan worked out of the maintenance department as a pipe-fitter throughout the plant. During this period, he worked primarily in the paper mill where asbestos fiber was mixed to make asbestos paper. His duties included repairing the paper machines in the mill once each week. Inches of dust would pile up in the area of repair behind the machines, and an air hose was used to blow away the dust before repairs began.

Doan could not remember or identify the ACL asbestos at the Lockland facility; however, employees of Celotex testified that ACL was one of many asbestos suppliers to the Lockland facility and that its fibers were used in the departments where Doan worked during the time Doan was there. A 1966 purchasing record introduced at trial showed that Celotex purchased ACL asbestos fibers for use in the Carey Temp department. Arthur Mueller, an employee in the research and development department at Celotex, testified that ACL and Johns-Manville fibers were used interchangeably in the pipe insulation. Although Celotex preferred to use the less expensive Carey Canadian asbestos when it was suitable, Howard Finn, a former employee of the purchasing department, testified that ACL was a "significant fiber" at the Lockland facility. It was used in cement products, papers, mill boards, and protective coatings. ACL asbestos was also used in buildings # 44 and # 28, two buildings in which Doan regularly worked during his years at Celotex, and in the paper mill.

B. Medical History

Doan left the company in 1983 after suffering serious back and head injuries in a work-related accident. When Doan left the company, he suffered from a variety of medical problems, including seizures, bronchitis, and emphysema. He smoked at least one pack of cigarettes a day for approximately forty years. He was diagnosed with asbestosis in 1986 and, one year later, with lung cancer. Doan died in August 1988, fifteen months after his lung cancer diagnosis.

Asbestosis is an incurable and progressive disease of the lung caused by prolonged exposure to asbestos. The district court made a finding that Doan suffered from asbestosis for fifteen months prior to his death. The court based this finding on Doan's medical records and on the testimony of the medical expert witnesses who testified at trial. The medical reports introduced into evidence indicated that, in April 1986, Drs. Lowry and Kelly diagnosed Doan with asbestosis. Plaintiff's experts, Dr. Dohn, a pulmonary specialist, and Dr. Mendelow, a pathologist, both testified that Doan suffered from asbestosis. They based their diagnoses on Doan's long history of exposure to asbestos and his symptoms of respiratory disease, as well as medical tests and x-ray reports. Medical reports showed that Doan suffered from the presence of "interstitial fibrotic patterns" and asbestos fibers in the lungs, and that he had a history of chronic coughing and shortness of breath, even while physically inactive.

Doan's autopsy report revealed findings that were consistent with asbestosis, but the pathologist who performed the autopsy could not identify any asbestos bodies in the lung tissue to confirm whether Doan had asbestosis. Subsequent laboratory tests, performed by Dr. C.K. Kim at the direction of the pathologist, revealed 1,344 asbestos bodies per gram net weight of lung tissue in Doan's lung tissue, a sufficient amount of asbestos bodies to establish occupational exposure to asbestos. Dr. Mendelow, plaintiff's expert, testified that individuals who are not exposed to asbestos normally have only 20 or more asbestos bodies per gram net weight of lung tissue.

Dr. Craighead, defendant's medical expert, located only three asbestos bodies in Doan's lung tissue. He testified that this was an insufficient number of asbestos fibers to support a diagnosis of asbestosis. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
983 F.2d 1066, 1992 U.S. App. LEXIS 36968, 1992 WL 379436, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vivian-doan-v-asbestos-corporation-ltd-gaf-corpora-ca6-1992.